Statistics
Publications
3
Citations
963
H-Index
3
Active since
1981
Affiliations
AbbVie (United States)(Current)
David McElligott is an author at AbbVie (United States) specializing in oncology, drug discovery, and medicine.
Publications per year
1981–2017
3
3
Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours
Loren Lasko, Clarissa G. Jakob, Rohinton Edalji et al. · Nature · 2017 · 858 citations · Full text
Michael R. Michaelides, Arthur F. Kluge, Michael A. Patane et al. · ACS Medicinal Chemistry Letters · 2017 · 73 citations · Full text
Immunologic aspects of the prostate
David M. Lubaroff, Craig W. Reynolds, Larry Canfield et al. · The Prostate · 1981 · 32 citations
Medicine, Immunology, Oncology +17
1–3 of 3